Literature DB >> 17468404

Extrapituitary prolactin promoter polymorphism in Czech patients with systemic lupus erythematosus and rheumatoid arthritis.

Markéta Fojtíková, Marie Cerná, Pavlína Cejková, Sárka Ruzicková, Ctibor Dostál.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17468404      PMCID： PMC1954624          DOI： 10.1136/ard.2006.061788

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus.

Authors:  A Stevens; D Ray; A Alansari; A Hajeer; W Thomson; R Donn; W E Ollier; J Worthington; J R Davis
Journal:  Arthritis Rheum       Date:  2001-10

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 3.  Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells.

Authors:  Christine M Grimaldi
Journal:  Curr Opin Rheumatol       Date:  2006-09       Impact factor: 5.006

4.  Revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett
Journal:  Bull Rheum Dis       Date:  1989

Review 5.  Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus.

Authors:  A Stevens; D W Ray; J Worthington; J R Davis
Journal:  Lupus       Date:  2001       Impact factor: 2.911

Review 6.  Endocrine, paracrine and autocrine actions of prolactin on immune cells.

Authors:  L Matera
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

Review 7.  Prolactin and prolactin-like polypeptides in rheumatoid arthritis.

Authors:  M Neidhart; R E Gay; S Gay
Journal:  Biomed Pharmacother       Date:  1999-06       Impact factor: 6.529

8.  Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.

Authors:  A Leaños-Miranda; G Cárdenas-Mondragón
Journal:  Rheumatology (Oxford)       Date:  2005-10-25       Impact factor: 7.580

9.  Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.

Authors:  Marta Mellai; Mara Giordano; Sandra D'Alfonso; Maurizio Marchini; Raffaella Scorza; M Danieli; Maurizio Leone; Isabella Ferro; Maria Liguori; Maria Trojano; Clara Ballerini; Luca Massacesi; Stefania Cannoni; Roberto Bomprezzi; Patricia Momigliano-Richiardi
Journal:  Hum Immunol       Date:  2003-02       Impact factor: 2.850

10.  Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma.

Authors:  B Gellersen; R Kempf; R Telgmann; G E DiMattia
Journal:  Mol Endocrinol       Date:  1994-03
  10 in total
  8 in total

1.  Meta-analysis of associations between functional prolactin -1149 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Clin Rheumatol       Date:  2015-02-28       Impact factor: 2.980

2.  Polymorphism of the extrapituitary prolactin promoter and systemic sclerosis.

Authors:  Markéta Fojtíková; Pavlína Cejková; Radim Bečvář; Jiří Vencovský; Jana Tomasová Studýnková; Marie Cerná
Journal:  Rheumatol Int       Date:  2009-12-19       Impact factor: 2.631

3.  HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population.

Authors:  Markéta Fojtíková; Peter Novota; Pavlína Cejková; Satu Pešičková; Dana Tegzová; Marie Cerná
Journal:  Rheumatol Int       Date:  2010-03-30       Impact factor: 2.631

4.  HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population.

Authors:  Markéta Fojtíková; Jirí Stolfa; Peter Novota; Pavlína Cejková; Ctibor Dostál; Marie Cerná
Journal:  Rheumatol Int       Date:  2009-01-28       Impact factor: 2.631

5.  The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility.

Authors:  Yvonne C Lee; Soumya Raychaudhuri; Jing Cui; Immaculata De Vivo; Bo Ding; Lars Alfredsson; Leonid Padyukov; Karen H Costenbader; Mark Seielstad; Robert R Graham; Lars Klareskog; Peter K Gregersen; Robert M Plenge; Elizabeth W Karlson
Journal:  Arthritis Rheum       Date:  2009-05

6.  Prolactin rs1341239 T allele may have protective role against the brick tea type skeletal fluorosis.

Authors:  Bing-Yun Li; Yan-Mei Yang; Yang Liu; Jing Sun; Yan Ye; Xiao-Na Liu; Hong-Xu Liu; Zhen-Qi Sun; Mang Li; Jing Cui; Dian-Jun Sun; Yan-Hui Gao
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

7.  Association of extrapituitary prolactin promoter polymorphism with disease susceptibility and anti-RNP antibodies in Mexican patients with systemic lupus erythematosus.

Authors:  Jorge Hernández-Bello; Claudia A Palafox-Sanchez; Samuel García-Arellano; Zyanya Reyes-Castillo; Ana L Pereira-Suárez; Isela Parra-Rojas; José E Navarro-Zarza; Ulises De la Cruz-Mosso; Nora M Torres-Carrillo; José Francisco Muñoz-Valle
Journal:  Arch Med Sci       Date:  2016-09-02       Impact factor: 3.318

8.  Prolactin and Dehydroepiandrosterone Levels in Women with Systemic Lupus Erythematosus: The Role of the Extrapituitary Prolactin Promoter Polymorphism at -1149G/T.

Authors:  Edward L Treadwell; Kenneth Wiley; Beverly Word; William Melchior; William H Tolleson; Neera Gopee; George Hammons; Beverly D Lyn-Cook
Journal:  J Immunol Res       Date:  2015-10-25       Impact factor: 4.818
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.